Mast cell modulation of the tumor microenvironment

The Tumor Immunoenvironment

Volumn , Issue , 2013, Pages 479-509

  Oldford, Sharon A ^a   Marshall, Jean S ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Adaptive immunity; Angiogenesis; Innate immunity; Mast cells; Tissue remodelling

Indexed keywords

EID: 84883823802     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-94-007-6217-6_20     Document Type: Chapter

References (150)

1. Abdel-Majid RM, Marshall JS (2004) Prostaglandin E2 induces degranulation-independent production of vascular endothelial growth factor by human mast cells. J Immunol 172:1227-1236
2. Asemissen AM, Scheibenbogen C, Letsch A, Hellstrand K, Thoren F, Gehlsen K et al (2005) Addition of histamine to interleukin 2 treatment augments type 1 T-cell responses in patients with melanoma in vivo: immunologic results from a randomized clinical trial of interleukin 2 with or without histamine (MP 104). Clin Cancer Res 11:290-297
3. Basu S, Binder RJ, Suto R, Anderson KM, Srivastava PK (2000) Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway. Int Immunol 12:1539-1546
4. Benitez-Bribiesca L, Wong A, Utrera D, Castellanos E (2001) The role of mast cell tryptase in neoangiogenesis of premalignant and malignant lesions of the uterine cervix. J Histochem Cytochem Off J Histochem Soc 49:1061-1062
5. Benyon RC, Bissonnette EY, Befus AD (1991) Tumor necrosis factor-alpha dependent cytotoxicity of human skin mast cells is enhanced by anti-IgE antibodies. J Immunol 147:2253-2258
6. Bischoff SC, Sellge G, Lorentz A, Sebald W, Raab R, Manns MP (1999) IL-4 enhances proliferation and mediator release in mature human mast cells. Proc Natl Acad Sci U S A 96:8080-8085
7. Bissell DM (2001) Chronic liver injury, TGF-beta, and cancer. Exp Mol Med 33:179-190
8. Boyce JA (2007) Mast cells and eicosanoid mediators: a system of reciprocal paracrine and autocrine regulation. Immunol Rev 217:168-185
9. Branitzki-Heinemann K, Okumura CY, Vollger L, Kawakami Y, Kawakami T, Naim HY et al (2012) A novel role for the transcription factor HIF-1alpha in the formation of mast cell extracellular traps. Biochem J 446:159-163
10. Brown MA, Hatfield JK, Walker ME, Sayed BA (2012) A game of kit and mouse: The Kit is still in the bag. Immunity 36:891-892 (author reply 3-4)
11. Brune M, Hansson M, Mellqvist UH, Hermodsson S, Hellstrand K (1996) NK cell-mediated killing of AML blasts: role of histamine, monocytes and reactive oxygen metabolites. Eur J Haematol 57:312-319
12. Burke SM, Issekutz TB, Mohan K, Lee PW, Shmulevitz M, Marshall JS (2008) Human mast cell activation with virus-associated stimuli leads to the selective chemotaxis of natural killer cells by a CXCL8-dependent mechanism. Blood 111:5467-5476
13. Burtin C, Noirot C, Paupe J, Scheinmann P (1983) Decreased blood histamine levels in patients with solid malignant tumours. Br J Cancer 47:367-372
14. Byrne SN, Beaugie C, O'Sullivan C, Leighton S, Halliday GM (2011) The immune-modulating cytokine and endogenous Alarmin interleukin-33 is upregulated in skin exposed to inflammatory UVB radiation. Am J Pathol 179:211-222
15. Cai SW, Yang SZ, Gao J, Pan K, Chen JY, Wang YL et al (2011) Prognostic significance of mast cell count following curative resection for pancreatic ductal adenocarcinoma. Surgery 149:576-584
16. Caruso RA, Ieni A, Fabiano V, Basile G, Inferrera C (2004) Perivascular mast cells in advanced gastric adenocarcinomas: an electron microscopic study. Anticancer Res 24:2257-2263
17. Caughey GH (2011) Mast cell proteases as protective and inflammatory mediators. Adv Exp Med Biol 716:212-234
18. Chan JK, Roth J, Oppenheim JJ, Tracey KJ, Vogl T, Feldmann M et al (2012) Alarmins: awaiting a clinical response. J Clin Investig 122:2711-2719
19. Ciocca DR, Calderwood SK (2005) Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 10:86-103
20. Conti P, Castellani ML, Kempuraj D, Salini V, Vecchiet J, Tete S et al (2007) Role of mast cells in tumor growth. Ann Clin Lab Sci 37:315-322
21. Coussens LM, Raymond WW, Bergers G, Laig-Webster M, Behrendtsen O, Werb Z et al (1999) Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev 13:1382-1397
22. Crivellato E, Beltrami C, Mallardi F, Ribatti D (2003) Paul Ehrlich's doctoral thesis: a milestone in the study of mast cells. Br J Haematol 123:19-21
23. Dawicki W, Marshall JS (2007) New and emerging roles for mast cells in host defence. Curr Opin Immunol 19:31-38
24. Dawicki W, Jawdat DW, Xu N, Marshall JS (2010) Mast cells, histamine, and IL-6 regulate the selective influx of dendritic cell subsets into an inflamed lymph node. J Immunol 184:2116-2123
25. de Souza DA Jr, Toso VD, Campos MR, Lara VS, Oliver C, Jamur MC (2012) Expression of mast cell proteases correlates with mast cell maturation and angiogenesis during tumor progression. PloS ONE 7:e40790
26. De Vries VC, Wasiuk A, Bennett KA, Benson MJ, Elgueta R, Waldschmidt TJ et al (2009) Mast cell degranulation breaks peripheral tolerance. Am J Transpl Off J Am Soc Transpl Am Soc Transpl Surg 9:2270-2280
27. Dery RE, Lin TJ, Befus AD, Milne CD, Moqbel R, Menard G et al (2000) Redundancy or celltype-specific regulation? Tumour necrosis factor in alveolar macrophages and mast cells. Immunology 99:427-434
28. Dethlefsen SM, Matsuura N, Zetter BR (1994) Mast cell accumulation at sites of murine tumor implantation: implications for angiogenesis and tumor metastasis. Invasion Metastasis 14:395-408
29. Detoraki A, Staiano RI, Granata F, Giannattasio G, Prevete N, de Paulis A et al (2009) Vascular endothelial growth factors synthesized by human lung mast cells exert angiogenic effects. J Allergy Clin Immunol 123:1142-1149, 9 e1-5
30. Di Nardo A, Vitiello A, Gallo RL (2003) Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide. J Immunol 170:2274-2278
31. Diaconu NC, Rummukainen J, Naukkarinen A, Matto M, Harvima RJ, Pelkonen J et al (2011) Mast cell chymase is present in uterine cervical carcinoma and it detaches viable and growing cervical squamous carcinoma cells from substratum in vitro. Arch Dermatol Res 303:499-512
32. Drobits B, Holcmann M, Amberg N, Swiecki M, Grundtner R, Hammer M et al (2012) Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells. J Clin Investig 122:575-585
33. Dudeck A, Dudeck J, Scholten J, Petzold A, Surianarayanan S, Kohler A et al (2011) Mast cells are key promoters of contact allergy that mediate the adjuvant effects of haptens. Immunity 34:973-984
34. Dvorak HF (1986) Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315:1650-1659
35. Elpek GO, Gelen T, Aksoy NH, Erdogan A, Dertsiz L, Demircan A et al (2001) The prognostic relevance of angiogenesis and mast cells in squamous cell carcinoma of the oesophagus. J Clin Pathol 54:940-944
36. Enoksson M, Lyberg K, Moller-Westerberg C, Fallon PG, Nilsson G, Lunderius-Andersson C (2011) Mast cells as sensors of cell injury through IL-33 recognition. J Immunol 186:2523-2528
37. Esposito I, Menicagli M, Funel N, Bergmann F, Boggi U, Mosca F et al (2004) Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma. J Clin Pathol 57:630-636
38. Feyerabend TB, Weiser A, Tietz A, Stassen M, Harris N, Kopf M et al (2011) Cre-mediated cell ablation contests mast cell contribution in models of antibody-and T cell-mediated autoimmunity. Immunity 35:832-844
39. Finotto S, Dolovich J, Denburg JA, Jordana M, Marshall JS (1994) Functional heterogeneity of mast cells isolated from different microenvironments within nasal polyp tissue. Clin Exp Immunol 95:343-350
40. Fischer M, Juremalm M, Olsson N, Backlin C, Sundstrom C, Nilsson K et al (2003) Expression of CCL5/RANTES by Hodgkin and Reed-Sternberg cells and its possible role in the recruitment of mast cells into lymphomatous tissue. Int J Cancer J Int du Cancer 107:197-201
41. Fleischmann A, Schlomm T, Kollermann J, Sekulic N, Huland H, Mirlacher M et al (2009) Immunological microenvironment in prostate cancer: high mast cell densities are associated with favorable tumor characteristics and good prognosis. Prostate 69:976-981
42. Folkman J (1990) What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82:4-6
43. Forward NA, Furlong SJ, Yang Y, Lin TJ, Hoskin DW (2009) Mast cells down-regulate CD4+CD25+ T regulatory cell suppressor function via histamine H1 receptor interaction. J Immunol 183:3014-3022
44. Gailit J, Marchese MJ, Kew RR, Gruber BL (2001) The differentiation and function of myofibroblasts is regulated by mast cell mediators. J Invest Dermatol 117:1113-1119
45. Galli SJ, Tsai M (2008) Mast cells: versatile regulators of inflammation, tissue remodeling, host defense and homeostasis. J Dermatol Sci 49:7-19
46. Galli SJ, Nakae S, Tsai M (2005) Mast cells in the development of adaptive immune responses. Nat Immunol 6:135-142
47. Gounaris E, Erdman SE, Restaino C, Gurish MF, Friend DS, Gounari F et al (2007) Mast cells are an essential hematopoietic component for polyp development. Proc Natl Acad Sci U S A 104:19977-19982
48. Grimbaldeston MA, Chen CC, Piliponsky AM, Tsai M, Tam SY, Galli SJ (2005) Mast celldeficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo. Am J Pathol 167:835-848
49. Grimbaldeston MA, Nakae S, Kalesnikoff J, Tsai M, Galli SJ (2007) Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nat Immunol 8:1095-1104
50. Groot Kormelink T, Abudukelimu A, Redegeld FA (2009) Mast cells as target in cancer therapy. Current Pharm Design 15:1868-1878
51. Gruber BL, Marchese MJ, Kew RR (1994) Transforming growth factor-beta 1 mediates mast cell chemotaxis. J Immunol 152:5860-5867
52. Gruber BL, Kew RR, Jelaska A, Marchese MJ, Garlick J, Ren S et al (1997) Human mast cells activate fibroblasts: Tryptase is a fibrogenic factor stimulating collagen messenger ribonucleic acid synthesis and fibroblast chemotaxis. J Immunol 158:2310-2317
53. Gulliksson M, Carvalho RF, Ulleras E, Nilsson G (2010) Mast cell survival and mediator secretion in response to hypoxia. PLoS ONE 5:e12360
54. Gurish MF, Austen KF (2012) Developmental origin and functional specialization of mast cell subsets. Immunity 37:25-33
55. Halova I, Draberova L, Draber P (2012) Mast cell chemotaxis-chemoattractants and signaling pathways. Frontiers Immunol 3:119
56. Hammad H, Kool M, Soullie T, Narumiya S, Trottein F, Hoogsteden HC et al (2007) Activation of the D prostanoid 1 receptor suppresses asthma by modulation of lung dendritic cell function and induction of regulatory T cells. J Exp Med 204:357-367
57. Hedstrom G, Berglund M, Molin D, Fischer M, Nilsson G, Thunberg U et al (2007) Mast cell infiltration is a favourable prognostic factor in diffuse large B-cell lymphoma. Br J Haematol 138:68-71
58. Hellstrand K, Hermodsson S (1991) Cell-to-cell mediated inhibition of natural killer cell proliferation by monocytes and its regulation by histamine H2-receptors. Scand J Immunol 34:741-752
59. Hellstrand K, Asea A, Hermodsson S (1994) Histaminergic regulation of antibody-dependent cellular cytotoxicity of granulocytes, monocytes, and natural killer cells. J Leukoc Biol 55:392-397
60. Hellstrand K, Hermodsson S, Brune M, Naredi P, Carneskog J, Mellqvist UH (1997) Histamine in cancer immunotherapy. Scand J Clin Lab Invest 57:193-202
61. Hsu CL, Neilsen CV, Bryce PJ (2010) IL-33 is produced by mast cells and regulates IgEdependent inflammation. PLoS ONE 5:e11944
62. Huang C, Friend DS, Qiu WT, Wong GW, Morales G, Hunt J et al (1998) Induction of a selective and persistent extravasation of neutrophils into the peritoneal cavity by tryptase mouse mast cell protease 6. J Immunol 160:1910-1919
63. Huang B, Lei Z, Zhang GM, Li D, Song C, Li B et al (2008) SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment. Blood 112:1269-1279
64. Iida N, Nakamoto Y, Baba T, Kakinoki K, Li YY, Wu Y et al (2008) Tumor cell apoptosis induces tumor-specific immunity in a CC chemokine receptor 1-and 5-dependent manner in mice. J Leukoc Biol 84:1001-1010
65. Irani AA, Schechter NM, Craig SS, DeBlois G, Schwartz LB (1986) Two types of human mast cells that have distinct neutral protease compositions. Proc Natl Acad Sci U S A 83:4464-4468
66. Irani AM, Goldstein SM, Wintroub BU, Bradford T, Schwartz LB (1991) Human mast cell carboxypeptidase. Selective localization to MCTC cells. J Immunol 147:247-253
67. Jawdat DM, Albert EJ, Rowden G, Haidl ID, Marshall JS (2004) IgE-mediated mast cell activation induces Langerhans cell migration in vivo. J Immunol 173:5275-5282
68. Jensen-Jarolim E, Achatz G, Turner MC, Karagiannis S, Legrand F, Capron M et al (2008) AllergoOncology: The role of IgE-mediated allergy in cancer. Allergy 63:1255-1266
69. Johansson A, Rudolfsson S, Hammarsten P, Halin S, Pietras K, Jones J et al (2010) Mast cells are novel independent prognostic markers in prostate cancer and represent a target for therapy. Am J Pathol 177:1031-1041
70. Juremalm M, Olsson N, Nilsson G (2002) Selective CCL5/RANTES-induced mast cell migration through interactions with chemokine receptors CCR1 and CCR4. Biochem Biophys Res Commun 297:480-485
71. Jutel M, Watanabe T, Klunker S, Akdis M, Thomet OA, Malolepszy J et al (2001) Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature 413:420-425
72. Kanbe N, Kurosawa M, Nagata H, Saitoh H, Miyachi Y (1999) Cord blood-derived human cultured mast cells produce transforming growth factor beta1. Clin Exp Allergy J British Soc Allergy Clinical Immunol 29:105-113
73. Kandere-Grzybowska K, Letourneau R, Kempuraj D, Donelan J, Poplawski S, Boucher W et al (2003) IL-1 induces vesicular secretion of IL-6 without degranulation from human mast cells. J Immunol 171:4830-4836
74. Kankkunen JP, Harvima IT, Naukkarinen A (1997) Quantitative analysis of tryptase and chymase containing mast cells in benign and malignant breast lesions. Int J Cancer J Int du Cancer 72:385-388
75. Katz HR, Stevens RL, Austen KF (1985) Heterogeneity of mammalian mast cells differentiated in vivo and in vitro. J Allergy Clin Immunol 76:250-259
76. Kim YJ, Hong KS, Chung JW, Kim JH, Hahm KB (2010) Prevention of colitis-associated carcinogenesis with infliximab. Cancer Prev Res 3:1314-1333
77. Kryczek I, Lange A, Mottram P, Alvarez X, Cheng P, Hogan M et al (2005) CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers. Cancer Res 65:465-472
78. Kunder CA, St John AL, Abraham SN (2011) Mast cell modulation of the vascular and lymphatic endothelium. Blood 118:5383-5393
79. Leal-Berumen I, O'Byrne P, Gupta A, Richards CD, Marshall JS (1995) Prostanoid enhancement of interleukin-6 production by rat peritoneal mast cells. J Immunol 154:4759-4767
80. Lieberman P (2011) The basics of histamine biology. Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol 106:S2-S5
81. Lin TJ, Issekutz TB, Marshall JS (2001) SDF-1 induces IL-8 production and transendothelial migration of human cord blood-derived mast cells. Int Arch Allergy Immunol 124:142-145
82. Lloyd HG, Ross L, Li KM, Ludowyke RI (1998) Evidence that IgE receptor stimulation increases adenosine release from rat basophilic leukaemia (RBL-2H3) cells. Pulm Pharmacol Ther 11:41-46
83. Maltby S, Khazaie K, McNagny KM (2009) Mast cells in tumor growth: angiogenesis, tissue remodelling and immune-modulation. Biochim Biophys Acta 1796:19-26
84. Mangia A, Malfettone A, Rossi R, Paradiso A, Ranieri G, Simone G et al (2011) Tissue remodelling in breast cancer: human mast cell tryptase as an initiator of myofibroblast differentiation. Histopathology 58:1096-1106
85. Marshall JS (2004) Mast-cell responses to pathogens. Nat Rev Immunol 4:787-799
86. Matsuo Y, Ochi N, Sawai H, Yasuda A, Takahashi H, Funahashi H et al (2009) CXCL8/IL-8 and CXCL12/SDF-1alpha co-operatively promote invasiveness and angiogenesis in pancreatic cancer. Int J Cancer J Int du Cancer 124:853-861
87. Mazzoni A, Leifer CA, Mullen GE, Kennedy MN, Klinman DM, Segal DM (2003) Cutting edge: histamine inhibits IFN-alpha release from plasmacytoid dendritic cells. J Immunol 170:2269-2273
88. McAlpine SM, Issekutz TB, Marshall JS (2012) Virus stimulation of human mast cells results in the recruitment of CD56(+) T cells by a mechanism dependent on CCR5 ligands. FASEB J 26:1280-1289
89. McCurdy JD, Olynych TJ, Maher LH, Marshall JS (2003) Cutting edge: distinct toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells. J Immunol 170:1625-1629
90. McLachlan JB, Shelburne CP, Hart JP, Pizzo SV, Goyal R, Brooking-Dixon R et al (2008) Mast cell activators: a new class of highly effective vaccine adjuvants. Nat Med 14:536-541
91. Melillo RM, Guarino V, Avilla E, Galdiero MR, Liotti F, Prevete N et al (2010) Mast cells have a protumorigenic role in human thyroid cancer. Oncogene 29:6203-6215
92. Mierke CT, Ballmaier M, Werner U, Manns MP, Welte K, Bischoff SC (2000) Human endothelial cells regulate survival and proliferation of human mast cells. J Exp Med 192:801-811
93. Mohtasham N, Babakoohi S, Salehinejad J, Montaser-Kouhsari L, Shakeri MT, Shojaee S et al (2010) Mast cell density and angiogenesis in oral dysplastic epithelium and low-and highgrade oral squamous cell carcinoma. Acta Odontol Scand 68:300-304
94. Moriarty CM, Stucky JL, Hamburger KW, Patil KD, Foley JF, Koefoot RR (1988) Blood histamine and solid malignant tumors. J Cancer Res Clin Oncol 114:588-592
95. Murata T, Aritake K, Matsumoto S, Kamauchi S, Nakagawa T, Hori M et al (2011) Prostagladin D2 is a mast cell-derived antiangiogenic factor in lung carcinoma. Proc Natl Acad Sci U S A 108:19802-19807
96. Nakae S, Suto H, Iikura M, Kakurai M, Sedgwick JD, Tsai M et al (2006) Mast cells enhance T cell activation: importance of mast cell costimulatory molecules and secreted TNF. J Immunol 176:2238-2248
97. Nakasone Y, Fujimoto M, Matsushita T, Hamaguchi Y, Huu DL, Yanaba M et al (2012) Hostderived MCP-1 and MIP-1alpha regulate protective anti-tumor immunity to localized and metastatic B16 melanoma. Am J Pathol 180:365-374
98. Nakayama T, Yao L, Tosato G (2004) Mast cell-derived angiopoietin-1 plays a critical role in the growth of plasma cell tumors. J Clin Investig 114:1317-1325
99. Negri E, Bosetti C, La Vecchia C, Levi F, Tomei F, Franceschi S (1999) Allergy and other selected diseases and risk of colorectal cancer. Eur J Cancer 35:1838-1841
100. Nigrovic PA, Gray DH, Jones T, Hallgren J, Kuo FC, Chaletzky B et al (2008) Genetic inversion in mast cell-deficient (Wsh) mice interrupts corin and manifests as hematopoietic and cardiac aberrancy. Am J Pathol 173:1693-1701
101. Norrby K (2002) Mast cells and angiogenesis. APMIS: Acta Pathologica, Microbiologica, et Immunologica Scandinavica 110:355-371
102. Noubade R, Milligan G, Zachary JF, Blankenhorn EP, del Rio R, Rincon M et al (2007) Histamine receptor H1 is required for TCR-mediated p38 MAPK activation and optimal IFNgamma production in mice. J Clin Investig 117:3507-3518
103. Oldford SA, Haidl ID, Howatt MA, Leiva CA, Johnston B, Marshall JS (2010) A critical role for mast cells and mast cell-derived IL-6 in TLR2-mediated inhibition of tumor growth. J Immunol 185:7067-7076
104. Olsson N, Piek E, ten Dijke P, Nilsson G (2000) Human mast cell migration in response to members of the transforming growth factor-beta family. J Leukoc Biol 67:350-356
105. Orimo A, Gupta PB, Sgroi DC, Arenzana-Seisdedos F, Delaunay T, Naeem R et al (2005) Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121:335-348
106. Ott VL, Cambier JC, Kappler J, Marrack P, Swanson BJ (2003) Mast cell-dependent migration of effector CD8+ T cells through production of leukotriene B4. Nat Immunol 4:974-981
107. Ownby DR, Ownby HE, Bailey J, Frederick J, Tilley B, Brooks SC et al (1985) Presurgical serum immunoglobulin concentrations and the prognosis of operable breast cancer in women. J Natl Cancer Inst 75:655-663
108. Pittoni P, Piconese S, Tripodo C, Colombo MP (2011) Tumor-intrinsic and-extrinsic roles of c-Kit: mast cells as the primary off-target of tyrosine kinase inhibitors. Oncogene 30:757-769
109. Polajeva J, Sjosten AM, Lager N, Kastemar M, Waern I, Alafuzoff I et al (2011) Mast cell accumulation in glioblastoma with a potential role for stem cell factor and chemokine CXCL12. PLoS ONE 6:e25222
110. Rajput AB, Turbin DA, Cheang MC, Voduc DK, Leung S, Gelmon KA et al (2008) Stromal mast cells in invasive breast cancer are a marker of favourable prognosis: a study of 4,444 cases. Breast Cancer Res Treat 107:249-257
111. Ribatti D, Crivellato E, Candussio L, Nico B, Vacca A, Roncali L et al (2001) Mast cells and their secretory granules are angiogenic in the chick embryo chorioallantoic membrane. Clin Exp Allergy J British Soc Allergy Clin Immunol 31:602-608
112. Ribatti D, Ranieri G, Nico B, Benagiano V, Crivellato E (2011) Tryptase and chymase are angiogenic in vivo in the chorioallantoic membrane assay. Int J Dev Biol 55:99-102
113. Riley JF, West GB (1953) The presence of histamine in tissue mast cells. J Physiol 120:528-537
114. Rizzo V, DeFouw DO (1996) Mast cell activation accelerates the normal rate of angiogenesis in the chick chorioallantoic membrane. Microvasc Res 52:245-257
115. Romero AI, Thoren FB, Brune M, Hellstrand K (2006) NKp46 and NKG2D receptor expression in NK cells with CD56dim and CD56bright phenotype: regulation by histamine and reactive oxygen species. Br J Haematol 132:91-98
116. Rudich N, Ravid K, Sagi-Eisenberg R (2012) Mast cell adenosine receptors function: a focus on the a3 adenosine receptor and inflammation. Frontiers Immunol 3:134
117. Saleem SJ, Martin RK, Morales JK, Sturgill JL, Gibb DR, Graham L et al (2012) Cutting edge: mast cells critically augment myeloid-derived suppressor cell activity. J Immunol 189:511-515
118. Samoszuk M, Corwin MA (2003) Acceleration of tumor growth and peri-tumoral blood clotting by imatinib mesylate (Gleevec). Int J Cancer J Int du Cancer 106:647-652
119. Samoszuk M, Kanakubo E, Chan JK (2005) Degranulating mast cells in fibrotic regions of human tumors and evidence that mast cell heparin interferes with the growth of tumor cells through a mechanism involving fibroblasts. BMC Cancer 5:121
120. Sarchio SN, Kok LF, O'Sullivan C, Halliday GM, Byrne SN (2012) Dermal mast cells affect the development of sunlight-induced skin tumours. Exp Dermatol 21:241-248
121. Schwartzbaum J, Ding B, Johannesen TB, Osnes LT, Karavodin L, Ahlbom A et al (2012) Association between prediagnostic IgE levels and risk of glioma. J Natl Cancer Inst 104:1251-1259
122. Sherman PW, Holland E, Sherman JS (2008) Allergies: Their role in cancer prevention. Q Rev Biol 83:339-362
123. Shin K, Nigrovic PA, Crish J, Boilard E, McNeil HP, Larabee KS et al (2009) Mast cells contribute to autoimmune inflammatory arthritis via their tryptase/heparin complexes. J Immunol 182:647-656
124. Simon T, Laszlo V, Falus A (2011) Impact of histamine on dendritic cell functions. Cell Biol Int 35:997-1000
125. Sinnamon MJ, Carter KJ, Sims LP, Lafleur B, Fingleton B, Matrisian LM (2008) A protective role of mast cells in intestinal tumorigenesis. Carcinogenesis 29:880-886
126. Soucek L, Lawlor ER, Soto D, Shchors K, Swigart LB, Evan GI (2007) Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors. Nat Med 13:1211-1218
127. Soule BP, Brown JM, Kushnir-Sukhov NM, Simone NL, Mitchell JB, Metcalfe DD (2007) Effects of gamma radiation on FcepsilonRI and TLR-mediated mast cell activation. J Immunol 179:3276-3286
128. Starkey JR, Crowle PK, Taubenberger S (1988) Mast-cell-deficient W/Wv mice exhibit a decreased rate of tumor angiogenesis. Int J Cancer J Int du Cancer 42:48-52
129. Stevens RL, Adachi R (2007) Protease-proteoglycan complexes of mouse and human mast cells and importance of their beta-tryptase-heparin complexes in inflammation and innate immunity. Immunol Rev 217:155-167
130. Sumbayev VV, Yasinska I, Oniku AE, Streatfield CL, Gibbs BF (2012) Involvement of hypoxiainducible factor-1 in the inflammatory responses of human LAD2 mast cells and basophils. PLoS ONE 7:e34259
131. Theiner G, Gessner A, Lutz MB (2006) The mast cell mediator PGD2 suppresses IL-12 release by dendritic cells leading to Th2 polarized immune responses in vivo. Immunobiology 211:463-472
132. Theoharides TC, Conti P (2004) Mast cells: The Jekyll and Hyde of tumor growth. Trends Immunol 25:235-241
133. Theoharides TC, Alysandratos KD, Angelidou A, Delivanis DA, Sismanopoulos N, Zhang B et al (2012) Mast cells and inflammation. Biochim Biophys Acta 1822:21-33
134. Tkaczyk C, Okayama Y, Metcalfe DD, Gilfillan AM (2004) Fcgamma receptors on mast cells: activatory and inhibitory regulation of mediator release. Int Arch Allergy Immunol 133:305-315
135. Toth-Jakatics R, Jimi S, Takebayashi S, Kawamoto N (2000) Cutaneous malignant melanoma: correlation between neovascularization and peritumor accumulation of mast cells overexpressing vascular endothelial growth factor. Hum Pathol 31:955-960
136. Tunis MC, Dawicki W, Carson KR, Wang J, Marshall JS (2012) Mast cells and IgE activation do not alter the development of oral tolerance in a murine model. J Allergy Clin Immunol 130:705-15
137. Van Nguyen H, Di Girolamo N, Jackson N, Hampartzoumian T, Bullpitt P, Tedla N et al (2011) Ultraviolet radiation-induced cytokines promote mast cell accumulation and matrix metalloproteinase production: potential role in cutaneous lupus erythematosus. Scand J Rheumatol 40:197-204
138. Vanbervliet B, Akdis M, Vocanson M, Rozieres A, Benetiere J, Rouzaire P et al (2011) Histamine receptor H1 signaling on dendritic cells plays a key role in the IFN-gamma/IL-17 balance in T cell-mediated skin inflammation. J Allergy Clin Immunol 127:943-953
139. von Stebut E, Metz M, Milon G, Knop J, Maurer M (2003) Early macrophage influx to sites of cutaneous granuloma formation is dependent on MIP-1alpha/beta released from neutrophils recruited by mast cell-derived TNFalpha. Blood 101:210-215
140. Wang Z, Macleod DT, Di Nardo A (2012) Commensal bacteria lipoteichoic acid increases skin mast cell antimicrobial activity against vaccinia viruses. J Immunol 189:1551-1558
141. Wedemeyer J, Galli SJ (2005) Decreased susceptibility of mast cell-deficient Kit(W)/Kit(W-v) mice to the development of 1, 2-dimethylhydrazine-induced intestinal tumors. Lab Investig J Tech Methods Pathol 85:388-396
142. Welsh TJ, Green RH, Richardson D, Waller DA, O'Byrne KJ, Bradding P (2005) Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-smallcell lung cancer. J Clin Oncol 23:8959-8967
143. Willox I, Mirkina I, Westwick J, Ward SG (2010) Evidence for PI3K-dependent CXCR3 agonistinduced degranulation of human cord blood-derived mast cells. Mol Immunol 47:2367-2377
144. Xia Q, Wu XJ, Zhou Q, Jing Z, Hou JH, Pan ZZ et al (2011) No relationship between the distribution of mast cells and the survival of stage IIIB colon cancer patients. J Transl Med 9:88
145. Xiang M, Gu Y, Zhao F, Lu H, Chen S, Yin L (2010) Mast cell tryptase promotes breast cancer migration and invasion. Oncol Rep 23:615-619
146. Yang Z, Zhang B, Li D, Lv M, Huang C, Shen GX et al (2010) Mast cells mobilize myeloidderived suppressor cells and Treg cells in tumor microenvironment via IL-17 pathway in murine hepatocarcinoma model. PLoS ONE 5:e8922
147. Yang XD, Ai W, Asfaha S, Bhagat G, Friedman RA, Jin G et al (2011) Histamine deficiency promotes inflammation-associated carcinogenesis through reduced myeloid maturation and accumulation of CD11b+Ly6G+ immature myeloid cells. Nat Med 17:87-95
148. Younan G, Suber F, Xing W, Shi T, Kunori Y, Abrink M et al (2010) The inflammatory response after an epidermal burn depends on the activities of mouse mast cell proteases 4 and 5. J Immunol 185:7681-7690
149. Zhang W, Stoica G, Tasca SI, Kelly KA, Meininger CJ (2000) Modulation of tumor angiogenesis by stem cell factor. Cancer Res 60:6757-6762
150. Zhu XQ, Lv JQ, Lin Y, Xiang M, Gao BH, Shi YF (2007) Expression of chemokines CCL5 and CCL11 by smooth muscle tumor cells of the uterus and its possible role in the recruitment of mast cells. Gynecol Oncol 105:650-656